NCT06447545

Brief Summary

This study aims to address the existing gap in knowledge by conducting a comprehensive comparison of the incidence of pain and common bile duct injuries in patients undergoing laparoscopic cholecystectomy using Low pressure pneumoperitoneum versus high pressure pneumoperitoneum.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
82

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 19, 2024

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 19, 2024

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

May 24, 2024

Completed
14 days until next milestone

First Posted

Study publicly available on registry

June 7, 2024

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2025

Completed
Last Updated

December 4, 2024

Status Verified

June 1, 2024

Enrollment Period

Same day

First QC Date

May 24, 2024

Last Update Submit

December 2, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • The incidence of pain and common bile duct injury in patients undergoing laparoscopic cholecystectomy using Low pressure pneumoperitoneum is less versus High pressure pneumoperitoneum.

    Pain will accessed using VAS. Pain (VAS): The Visual Analogue Scale (VAS) measures pain intensity. The VAS consists of a 10cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be'). It was assessed at 4, 8, 12 hours post-operatively by using Visual Analogue Pain Scale. No pain \|0\_\_\_\_1\_\_\_\_2\_\_\_\_3\_\_\_\_4\_\_\_\_5\_\_\_\_6\_\_\_\_7\_\_\_\_8\_\_\_\_9\_\_\_\_10\| sever pain Mild pain-Moderate Pain-Sever pain Visual Analogue Pain Scale And CBD injury will be accessed using bismuth classification. CBD INJURY: Injury to CBD Is Classified According to Bismuth Classification: Type I is a low injury with a stump length more than 2 cm. Type II is a middle level injury with a stump length less than 2 cm. Type III is a high-level injury without common hepatic duct available but preserved confluence. Type IV involves loss of hepatic confluence with no communication between right and left ducts.

    6 months

Study Arms (2)

Low Pressure Pneumoperitoneum

OTHER

low-pressure pneumoperitoneum in which the pressure is (6-10 mmHg)

Device: Changing pressure of Pneumoperitoneum to 6-10 mmHg

High Pressure Pneumoperitoneum

OTHER

High-pressure pneumoperitoneum, involving insufflation pressures typically ranging from 12 to 15 mmHg or higher

Device: Changing pressure of Pneumoperitoneum to 12-15 mmHg

Interventions

Result of changing pneumoperitoneum pressure on CBD injury and pain

Also known as: Low Pressure Pneumoperitoneum
Low Pressure Pneumoperitoneum

Result of changing pneumoperitoneum pressure on CBD injury and pain

Also known as: High Pressure Pneumoperitoneum
High Pressure Pneumoperitoneum

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients from both genders
  • Patients undergoing laparoscopic cholecystectomy for cholelithiasis.

You may not qualify if:

  • Patients with cardiac abnormalities.
  • Patients with previous abdominal surgeries.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gulab Devi Hospital

Lahore, PUN, 54000, Pakistan

RECRUITING

MeSH Terms

Conditions

PneumoperitoneumPain, Postoperative

Condition Hierarchy (Ancestors)

Peritoneal DiseasesDigestive System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • M. Zia-ul-Miraj Ahmad, MBBS,FRCS

    Gulab Devi Hospital

    STUDY DIRECTOR

Central Study Contacts

Zain Himayoun, MBBS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 24, 2024

First Posted

June 7, 2024

Study Start

May 19, 2024

Primary Completion

May 19, 2024

Study Completion

November 30, 2025

Last Updated

December 4, 2024

Record last verified: 2024-06

Locations